Surface-Active Agents: Clinical Trials

6 trials of Surface-Active Agents, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 2 unknown, 1 active not recruiting, 1 terminated. 6 Phase 3, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 36Completed 2, Unknown 2, Active not recruiting 1, Terminated 1
Phase 21Unknown 1

Follow Surface-Active Agents: new trials by email Literature Review of Surface-Active Agents trials Research Report on Surface-Active Agents

Trials (filtered) newest first · largest first

All 6 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Daily Chlorexidine Bath for Health Care Associated Infection Prevention
2% chlorhexidine digluconate solution with surface-active agents, Usual Baths - Health Care Associated Infection, Ventilator Associated Pneumonia
Phase 3CompletedHospital do Coracao157302022-08-032024-06-13
The Budesonide in Babies (BiB) Trial
budesonide (Pulmicort nebulizing suspension)., surfactant (poractant alfa;Curosurf) - Bronchopulmonary Dysplasia (BPD), Respiratory Distress Syndrome
Phase 3Active not recruitingNICHD Neonatal Research Network6422021-04-012026-04-15
Intratracheal Vitamin A Administration With Surfactant for Newborn Respiratory Distress Syndrome
surfactant, surfactant+vitamin A - RDS, Infant, Newborn
Phase 3UnknownThird Military Medical University1002012-01-012011-07-26
Surfactant Positive Airway Pressure and Pulse Oximetry Trial
Surfactant, Continuous Positive Airway Pressure (CPAP), Supplemental oxygen with target saturation of 85 to 89% - Infant, Newborn, Diseases, Other Preterm Infants
Phase 3CompletedNICHD Neonatal Research Network13162005-02-012019-04-18
The Use of Surfactant in Lung Transplantation: A Randomized Control Pilot Study
Surfactant (calfactant) - Lung Transplantation, Primary Graft Dysfunction
Phase 2 / Phase 3UnknownRabin Medical Center422005-01-012007-07-25
Phase III Randomized Study of Lucinactant in Full Term Newborn Infants With Meconium Aspiration Syndrome
Lucinactant, Standard Care - Meconium Aspiration
Phase 3TerminatedWindtree Therapeutics692000-03-012012-05-03

Conditions studied

Bronchopulmonary Dysplasia (2)  ·  Premature Birth (2)  ·  Cross Infection (1)  ·  Infant, Newborn, Diseases (1)  ·  Meconium Aspiration Syndrome (1)  ·  Pneumonia, Ventilator-Associated (1)  ·  Primary Graft Dysfunction (1)  ·  Rare Diseases (1)  ·  Respiratory Distress Syndrome (1)  ·  Respiratory Tract Diseases (1)  ·  Retinopathy of Prematurity (1)

Sponsors

NICHD Neonatal Research Network (2)  ·  Hospital do Coracao (1)  ·  Rabin Medical Center (1)  ·  Third Military Medical University (1)  ·  Windtree Therapeutics (1)

Countries

United States (3)  ·  Brazil (1)  ·  China (1)  ·  Israel (1)

Top investigators

Abbot R. Laptook, MD (1)  ·  Abhik Das, PhD (1)  ·  Alexandre B Cavalcanti, M.D (1)  ·  Barbara J. Stoll, MD (1)  ·  Brenda B. Poindexter, MD MS (1)  ·  Bruno M Tomazini, M.D (1)  ·  Edward F. Bell, MD (1)  ·  Kathleen A. Kennedy, MD MPH (1)  ·  Krisa P. Van Meurs, MD (1)  ·  Kristi L. Watterberg, MD (1)  ·  Kurt Schibler, MD (1)  ·  Michele C. Walsh, MD MS (1)  ·  MordechaI R Kramer, Prof (1)  ·  Namasivayam Ambalavanan, MD (1)

Results publications

PMID 20472937, PMID 20472939, PMID 20587676, PMID 22371462, PMID 22738947, PMID 23268664, PMID 24725582, PMID 24876196, PMID 25425651, PMID 25554820, PMID 27344218, PMID 28279433, PMID 28600154, PMID 30292492, PMID 30692613, PMID 35715492, PMID 37640232, PMID 40571094, PMID 41026481, PMID 41732706

NIH funding

M01RR000633 (1), M01RR000750 (1), M01RR008084 (1), U10HD021364 (1), U10HD021373 (1), U10HD021385 (1), U10HD021397 (1), U10HD027851 (1), U10HD027853 (1), U10HD027856 (1), U10HD027871 (1), U10HD027880 (1), U10HD027904 (1), U10HD034216 (1), U10HD036790 (1)